Literature DB >> 31790721

Glial neuroimmune signaling in opioid reward.

Hong Zhang1, Tally M Largent-Milnes1, Todd W Vanderah2.   

Abstract

The opioid epidemic is a growing public concern affecting millions of people worldwide. Opioid-induced reward is the initial and key process leading to opioid abuse and addiction. Therefore, a better understanding of opioid reward may be helpful in developing a treatment for opioid addiction. Emerging evidence suggests that glial cells, particularly microglia and astrocytes, play an essential role in modulating opioid reward. Indeed, glial cells and their associated immune signaling actively regulate neural activity and plasticity, and directly modulate opioid-induced rewarding behaviors. In this review, we describe the neuroimmune mechanisms of how glial cells affect synaptic transmission and plasticity as well as how opioids can activate glial cells affecting the glial-neuronal interaction. Last, we summarize current attempts of applying glial modulators in treating opioid reward.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocyte; Microglia; Neuroimmune signaling; Neuroinflammation; Opioid reward

Mesh:

Year:  2019        PMID: 31790721      PMCID: PMC6946383          DOI: 10.1016/j.brainresbull.2019.11.012

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  140 in total

1.  Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes.

Authors:  Steven R Laviolette; Karim Nader; Derek van der Kooy
Journal:  Behav Brain Res       Date:  2002-02-01       Impact factor: 3.332

2.  The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers.

Authors:  Ziva D Cooper; Kirk W Johnson; Martina Pavlicova; Andrew Glass; Suzanne K Vosburg; Maria A Sullivan; Jeanne M Manubay; Diana M Martinez; Jermaine D Jones; Phillip A Saccone; Sandra D Comer
Journal:  Addict Biol       Date:  2015-05-14       Impact factor: 4.280

Review 3.  Microglia: Dynamic Mediators of Synapse Development and Plasticity.

Authors:  Yuwen Wu; Lasse Dissing-Olesen; Brian A MacVicar; Beth Stevens
Journal:  Trends Immunol       Date:  2015-10       Impact factor: 16.687

4.  Remodeling of dendrites and spines in the C1q knockout model of genetic epilepsy.

Authors:  Yunyong Ma; Anu Ramachandran; Naomi Ford; Isabel Parada; David A Prince
Journal:  Epilepsia       Date:  2013-04-26       Impact factor: 5.864

5.  An adaptive role of TNFα in the regulation of striatal synapses.

Authors:  Gil M Lewitus; Horia Pribiag; Rachna Duseja; Michel St-Hilaire; David Stellwagen
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

Review 6.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

Review 7.  Common Brain Mechanisms of Chronic Pain and Addiction.

Authors:  Igor Elman; David Borsook
Journal:  Neuron       Date:  2016-01-06       Impact factor: 17.173

8.  Kappa-opioid modulation of human microglial cell superoxide anion generation.

Authors:  S Hu; P K Peterson; C C Chao
Journal:  Biochem Pharmacol       Date:  1998-08-01       Impact factor: 5.858

Review 9.  Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.

Authors:  Yasmin L Hurd; Michelle Yoon; Alex F Manini; Stephanie Hernandez; Ruben Olmedo; Maria Ostman; Didier Jutras-Aswad
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.

Authors:  Puja Seth; Lawrence Scholl; Rose A Rudd; Sarah Bacon
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-03-30       Impact factor: 17.586

View more
  4 in total

1.  The role of gut-immune-brain signaling in substance use disorders.

Authors:  Kelsey E Lucerne; Drew D Kiraly
Journal:  Int Rev Neurobiol       Date:  2020-10-24       Impact factor: 4.280

Review 2.  Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.

Authors:  Mark D Namba; Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive; Janet L Neisewander
Journal:  Front Neurosci       Date:  2021-04-15       Impact factor: 4.677

3.  The Effects of Repeated Morphine Treatment on the Endogenous Cannabinoid System in the Ventral Tegmental Area.

Authors:  Hong Zhang; Austin A Lipinski; Erika Liktor-Busa; Angela F Smith; Aubin Moutal; Rajesh Khanna; Paul R Langlais; Tally M Largent-Milnes; Todd W Vanderah
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

Review 4.  A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder.

Authors:  Madelyn H Ray; Benjamin R Williams; Madeline K Kuppe; Camron D Bryant; Ryan W Logan
Journal:  Front Integr Neurosci       Date:  2022-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.